Evogene (EVGN) Reaches New 1-Year Low at $3.36
Evogene Ltd. (NASDAQ:EVGN)’s share price reached a new 52-week low on Wednesday . The company traded as low as $3.36 and last traded at $3.45, with a volume of 25900 shares. The stock had previously closed at $3.44.
A hedge fund recently raised its stake in Evogene stock. Vanguard Group Inc. grew its holdings in shares of Evogene Ltd. (NASDAQ:EVGN) by 4.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 436,225 shares of the biotechnology company’s stock after buying an additional 17,391 shares during the quarter. Vanguard Group Inc. owned 1.70% of Evogene worth $2,443,000 as of its most recent SEC filing. 30.94% of the stock is owned by hedge funds and other institutional investors.
COPYRIGHT VIOLATION WARNING: “Evogene (EVGN) Reaches New 1-Year Low at $3.36” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another website, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/12/20/evogene-evgn-reaches-new-1-year-low-at-3-36.html.
Evogene Ltd. (Evogene) is a biotechnology company for the improvement of crop productivity. The Company is engaged in developing seed traits for improved yield and abiotic stress tolerance, seed traits for biotic stress resistance, herbicides and bio-stimulants. The Company operates a seed business under its subsidiary Evofuel Ltd.
Receive News & Ratings for Evogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evogene and related companies with MarketBeat.com's FREE daily email newsletter.